Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

The influence of self-criticism on depression symptoms among ambulatory patients with inflammatory bowel disease.

Trindade IA, Irons C, Ferreira C, Portela F, Pinto-Gouveia J.

Clin Psychol Psychother. 2019 Nov;26(6):743-750. doi: 10.1002/cpp.2398. Epub 2019 Oct 28.

PMID:
31614035
2.

Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: a Systematic Review.

Estevinho MM, Rocha C, Correia L, Lago P, Ministro P, Portela F, Trindade E, Afonso J, Peyrin-Biroulet L, Magro F; GEDII (Portuguese IBD Group).

Clin Gastroenterol Hepatol. 2019 Sep 14. pii: S1542-3565(19)31003-1. doi: 10.1016/j.cgh.2019.08.063. [Epub ahead of print] Review.

PMID:
31526845
3.

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.

Magro F, Lopes S, Silva M, Coelho R, Portela F, Branquinho D, Correia L, Fernandes S, Cravo M, Caldeira P, Tavares de Sousa H, Patita M, Lago P, Ramos J, Afonso J, Redondo I, Machado P, Philip G, Lopes J, Carneiro F.

Therap Adv Gastroenterol. 2019 Aug 30;12:1756284819869141. doi: 10.1177/1756284819869141. eCollection 2019.

4.

Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.

Roseira J, Magro F, Fernandes S, Simões C, Portela F, Vieira AI, Patita M, Leal C, Lago P, Caldeira P, Gago T, Currais P, Dias CC, Santiago M, Dias S, Tavares de Sousa H; GEDII.

Inflamm Bowel Dis. 2019 Aug 27. pii: izz185. doi: 10.1093/ibd/izz185. [Epub ahead of print]

PMID:
31504518
5.

Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.

Magro F, Lopes J, Borralho P, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Cravo M, Dias CC, Afonso J, Portela F, Santiago M, Geboes K, Carneiro F.

J Crohns Colitis. 2019 Sep 4. pii: jjz123. doi: 10.1093/ecco-jcc/jjz123. [Epub ahead of print]

PMID:
31504348
6.

Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy.

Portela F, Ministro P, de Deus J, Cravo M, Cotter J, Duque G, Ferreira F, Rosa B, Ferreira PL, Dias CC, Magro F; Portuguese IBD Study Group (GEDII).

Digestion. 2019 Sep 6:1-7. doi: 10.1159/000501823. [Epub ahead of print]

PMID:
31494658
7.

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale.

Santiago M, Magro F, Correia L, Portela F, Ministro P, Lago P, Dias CC.

Therap Adv Gastroenterol. 2019 Aug 21;12:1756284819860044. doi: 10.1177/1756284819860044. eCollection 2019.

8.

Total arterial revascularization strategies: A meta-analysis of propensity score-matched observational studies.

Urso S, Sadaba R, González JM, Nogales E, Pettinari M, Tena MÁ, Paredes F, Portela F.

J Card Surg. 2019 Sep;34(9):837-845. doi: 10.1111/jocs.14169. Epub 2019 Aug 2. Review.

PMID:
31376215
9.

EternaBrain: Automated RNA design through move sets and strategies from an Internet-scale RNA videogame.

Koodli RV, Keep B, Coppess KR, Portela F; Eterna participants, Das R.

PLoS Comput Biol. 2019 Jun 27;15(6):e1007059. doi: 10.1371/journal.pcbi.1007059. eCollection 2019 Jun.

10.

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.

Magro F, Lopes S, Silva M, Coelho R, Portela F, Branquinho D, Correia L, Fernandes S, Cravo M, Caldeira P, Sousa HT, Patita M, Lago P, Ramos J, Afonso J, Redondo I, Machado P, Cornillie F, Lopes J, Carneiro F; Portuguese IBD Group [GEDII].

J Crohns Colitis. 2019 Oct 28;13(11):1387-1393. doi: 10.1093/ecco-jcc/jjz071.

PMID:
30989180
11.

Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.

Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa.

J Crohns Colitis. 2019 May 27;13(6):814. doi: 10.1093/ecco-jcc/jjy211. No abstract available.

PMID:
30951596
12.

Sodium butyrate inhibits planktonic cells and biofilms of Trichosporon spp.

Cordeiro RA, Aguiar ALR, Pereira VS, Pereira LMG, Portela FVM, Brilhante RSN, Camargo ZP, Sidrim JJC, Castelo-Branco DSCM, Rocha MFG.

Microb Pathog. 2019 May;130:219-225. doi: 10.1016/j.micpath.2019.03.013. Epub 2019 Mar 14.

PMID:
30878621
13.

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F.

World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. eCollection 2019. Review.

14.

Bilateral internal thoracic artery versus single internal thoracic artery: a meta-analysis of propensity score-matched observational studies.

Urso S, Nogales E, González JM, Sadaba R, Tena MÁ, Bellot R, Ríos L, Portela F.

Interact Cardiovasc Thorac Surg. 2019 Mar 8. pii: ivz037. doi: 10.1093/icvts/ivz037. [Epub ahead of print]

PMID:
30848794
15.

Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years.

Dias CC, Santiago M, Correia L, Portela F, Ministro P, Lago P, Trindade E, Freitas A, Magro F; GEDII.

Dig Liver Dis. 2019 Jul;51(7):952-960. doi: 10.1016/j.dld.2019.01.016. Epub 2019 Feb 6.

PMID:
30826276
16.

Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.

Cordeiro RA, Pereira LMG, de Sousa JK, Serpa R, Andrade ARC, Portela FVM, Evangelista AJJ, Sales JA, Aguiar ALR, Mendes PBL, Brilhante RSN, Sidrim JJDC, Castelo-Branco DSCM, Rocha MFG.

Med Mycol. 2019 Nov 1;57(8):1038-1045. doi: 10.1093/mmy/myy160.

PMID:
30649480
17.

Genome-wide interrogation of extracellular vesicle biology using barcoded miRNAs.

Lu A, Wawro P, Morgens DW, Portela F, Bassik MC, Pfeffer SR.

Elife. 2018 Dec 17;7. pii: e41460. doi: 10.7554/eLife.41460.

18.

Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.

Magro F, Dias CC, Portela F, Miranda M, Fernandes S, Bernardo S, Ministro P, Lago P, Rosa I, Pita I, Correia L, Rodrigues PP; GEDII [Portuguese IBD Group].

J Crohns Colitis. 2019 Mar 30;13(4):401-409. doi: 10.1093/ecco-jcc/jjy168.

PMID:
30329032
19.

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia.

Perdigoto DN, Lopes S, Portela F, Cipriano MA, Tomé L.

GE Port J Gastroenterol. 2018 Jun;25(4):198-200. doi: 10.1159/000481538. Epub 2017 Oct 28. No abstract available.

20.

Levosimendan versus placebo in cardiac surgery: a systematic review and meta-analysis.

Tena MÁ, Urso S, González JM, Santana L, Sadaba R, Juarez P, González L, Portela F.

Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):677-685. doi: 10.1093/icvts/ivy133.

PMID:
29718383
21.

Ulcerative Colitis: Are We Neglecting Its Progressive Character.

Massinha P, Portela F, Campos S, Duque G, Ferreira M, Mendes S, Ferreira AM, Sofia C, Tomé L.

GE Port J Gastroenterol. 2018 Mar;25(2):74-79. doi: 10.1159/000481263. Epub 2017 Oct 20.

22.

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.

Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa [listed at the end of the article] .

J Crohns Colitis. 2018 May 25;12(6):687-694. doi: 10.1093/ecco-jcc/jjy023. Erratum in: J Crohns Colitis. 2019 May 27;13(6):814.

PMID:
29490024
23.

The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis.

Dias CC, Portela F, Fernandes S, Ministro P, Lago P, Rosa I, Correia L, Magro F; on behalf GEDII.

Dig Liver Dis. 2018 May;50(5):462-468. doi: 10.1016/j.dld.2018.01.135. Epub 2018 Feb 1.

PMID:
29456097
24.

Metastatic Crohn's disease despite infliximab therapy.

Campos S, Coutinho I, Cardoso JC, Portela F.

An Bras Dermatol. 2017;92(5 Suppl 1):104-106. doi: 10.1590/abd1806-4841.20175713.

25.

Foraminal Deformation after Foraminal Enlargement with Rotary and Reciprocating Kinematics: A Scanning Electronic Microscopy Study.

Silva Santos AM, Portela FMSF, Coelho MS, Fontana CE, De Martin AS.

J Endod. 2018 Jan;44(1):145-148. doi: 10.1016/j.joen.2017.08.013. Epub 2017 Oct 21.

PMID:
29033083
26.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
27.

Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.

Gravito-Soares M, Gravito-Soares E, Portela F, Ferreira M, Sofia C.

Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016.

28.

Endoscopic ultrasound-guided ethanol ablation therapy for pancreatic insulinoma: an unusual strategy.

de Sousa Lages A, Paiva I, Oliveira P, Portela F, Carrilho F.

Endocrinol Diabetes Metab Case Rep. 2017 Apr 6;2017. pii: 16-0145. doi: 10.1530/EDM-16-0145. eCollection 2017.

29.

The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis.

Dias CC, Pereira Rodrigues P, Fernandes S, Portela F, Ministro P, Martins D, Sousa P, Lago P, Rosa I, Correia L, Moura Santos P, Magro F.

PLoS One. 2017 Feb 22;12(2):e0172165. doi: 10.1371/journal.pone.0172165. eCollection 2017.

30.

The who-when-why triangle of CAM use among Portuguese IBD patients.

Portela F, Dias CC, Caldeira P, Cravo M, Deus J, Gonçalves R, Lago P, Morna H, Peixe P, Ramos J, Sousa H, Tavares L, Vasconcelos H, Magro F, Ministro P.

Dig Liver Dis. 2017 Apr;49(4):388-396. doi: 10.1016/j.dld.2016.12.031. Epub 2017 Jan 6.

PMID:
28117198
31.

Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.

Magro F, Dias CC, Coelho R, Santos PM, Fernandes S, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Tavares Sousa H, Contente L, Morna H, Lopes S.

Inflamm Bowel Dis. 2017 Feb;23(2):289-297. doi: 10.1097/MIB.0000000000001007.

PMID:
28107278
32.

Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.

Campos ST, Portela FA, Tomé L.

Int J Colorectal Dis. 2017 May;32(5):645-650. doi: 10.1007/s00384-017-2752-5. Epub 2017 Jan 13.

PMID:
28084548
33.

Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.

Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII.

J Crohns Colitis. 2017 Apr 1;11(4):515. doi: 10.1093/ecco-jcc/jjw207. No abstract available.

PMID:
27927719
34.

Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.

Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII.

J Crohns Colitis. 2017 Apr 1;11(4):445-453. doi: 10.1093/ecco-jcc/jjw171. Erratum in: J Crohns Colitis. 2017 Apr 1;11(4):515.

PMID:
27683799
35.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F; ECCO.

J Crohns Colitis. 2017 Feb;11(2):135-149. doi: 10.1093/ecco-jcc/jjw169. Epub 2016 Sep 22.

PMID:
27660342
36.

Association between the location of colon polyps at baseline and surveillance colonoscopy - A retrospective study.

Oliveira A, Freire P, Souto P, Ferreira M, Mendes S, Lérias C, Amaro P, Portela F, Sofia C.

Rev Esp Enferm Dig. 2016 Sep;108(9):563-7. doi: 10.17235/reed.2016.4095/2015.

37.

Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.

Campos S, Portela F, Sousa P, Sofia C.

Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1313-9. doi: 10.1097/MEG.0000000000000704.

PMID:
27501126
38.

Iatrogenic Perforations During Colonoscopy In a Portuguese Population: A Study Including In and Out-Of-Hospital Procedures.

Campos S, Amaro P, Portela F, Sofia C.

GE Port J Gastroenterol. 2016 Jun 21;23(4):183-190. doi: 10.1016/j.jpge.2016.02.007. eCollection 2016 Jul-Aug.

39.

Erratum to: Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study.

Rovisco J, Duarte C, Batticciotto A, Sarzi-Puttini P, Draghessi A, Portela F, Gutierrez M.

BMC Musculoskelet Disord. 2016 Jun 1;17(1):241. No abstract available.

40.

Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.

Magro F, Lopes SI, Lopes J, Portela F, Cotter J, Lopes S, Moreira MJ, Lago P, Peixe P, Albuquerque A, Rodrigues S, Silva MR, Monteiro P, Lopes C, Monteiro L, Macedo G, Veloso L, Camila C, Afonso J, Geboes K, Carneiro F; Portuguese IBD group [GEDII].

J Crohns Colitis. 2016 Dec;10(12):1407-1416. Epub 2016 May 25.

PMID:
27226417
41.

Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study.

Portela F, Lago P, Cotter J, Gonçalves R, Vasconcelos H, Ministro P, Lopes S, Eusébio M, Morna H, Cravo M, Peixe P, Cremmers I, Sousa H, Deus J, Duarte M, Magro F; CAPOR Investigators and GEDII.

Digestion. 2016;93(3):214-20. doi: 10.1159/000443927. Epub 2016 Mar 25.

PMID:
27022722
42.

Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study.

Rovisco J, Duarte C, Batticcioto A, Sarzi-Puttini P, Dragresshi A, Portela F, Gutierrez M.

BMC Musculoskelet Disord. 2016 Feb 16;17:84. doi: 10.1186/s12891-016-0932-z. Erratum in: BMC Musculoskelet Disord. 2016;17(1):241.

43.

Left-Sided Portal Hypertension: A Sinister Entity.

Fernandes A, Almeida N, Ferreira AM, Casela A, Gomes D, Portela F, Camacho E, Sofia C.

GE Port J Gastroenterol. 2015 Oct 29;22(6):234-239. doi: 10.1016/j.jpge.2015.09.006. eCollection 2015 Nov-Dec.

44.

WSES guidelines for management of Clostridium difficile infection in surgical patients.

Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GA, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P.

World J Emerg Surg. 2015 Aug 20;10:38. doi: 10.1186/s13017-015-0033-6. eCollection 2015. Review.

45.

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO.

Rev Gastroenterol Mex. 2015 Jan-Mar;80(1):74-106. doi: 10.1016/j.rgmx.2014.10.008. Epub 2015 Mar 11. Spanish. No abstract available.

46.

Ectopic pancreas as a rare cause of obstructive jaundice.

Carvalho R, Freire P, Portela F, Gomes D, Andrade P, Bento A, Batista H, Cipriano MA, Sofia C.

Rev Esp Enferm Dig. 2014 Dec;106(8):557-8. No abstract available.

47.

Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence country.

Areia M, Alves S, Brito D, Cadime AT, Carvalho R, Saraiva S, Ferreira S, Moleiro J, Pereira AD, Carrasquinho J, Lopes L, Ramada J, Marcos-Pinto R, Pedroto I, Contente L, Eliseu L, Vieira AM, Sampaio M, Sousa HT, Almeida N, Gregório C, Portela F, Sofia C, Braga V, Baginha E, Bana e Costa T, Chagas C, Mendes LL, Magalhães-Costa P, Matos L, Gonçalves FR, Dinis-Ribeiro M.

J Gastrointestin Liver Dis. 2014 Dec;23(4):371-8. doi: 10.15403/jgld.2014.1121.234.hrq.

48.

Surveillance in ulcerative colitis: is chromoendoscopy-guided endomicroscopy always better than conventional colonoscopy? A randomized trial.

Freire P, Figueiredo P, Cardoso R, Donato MM, Ferreira M, Mendes S, Silva MR, Cipriano A, Ferreira AM, Vasconcelos H, Portela F, Sofia C.

Inflamm Bowel Dis. 2014 Nov;20(11):2038-45. doi: 10.1097/MIB.0000000000000176.

PMID:
25185683
49.

Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.

Freire P, Figueiredo P, Cardoso R, Manuel Donato M, Ferreira M, Mendes S, Silva MR, Cipriano MA, Ferreira AM, Vasconcelos H, Portela F, Sofia C.

Scand J Gastroenterol. 2014 Oct;49(10):1219-29. doi: 10.3109/00365521.2014.951390. Epub 2014 Aug 26.

PMID:
25157637
50.

Kinematic mapping reveals different spatial distributions of center of pressure high-speed regions under somatosensory loss.

Portela FM, Ferreira AS.

J Mot Behav. 2014;46(5):369-79. doi: 10.1080/00222895.2014.916651. Epub 2014 Jun 19.

PMID:
24945569

Supplemental Content

Loading ...
Support Center